Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 5, Pages 617-632
Publisher
Informa Healthcare
Online
2015-01-20
DOI
10.1517/14728222.2015.1005603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation
- (2015) Jennifer Munkley et al. Oncotarget
- Cancer Metabolism: New Validated Targets for Drug Discovery
- (2015) Federica Sotgia et al. Oncotarget
- Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells
- (2015) Sarah Jurmeister et al. Oncotarget
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Use of Metformin in Patients with Prostate Cancer and the Risk of Death
- (2014) L. Bensimon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Small Molecule Drug A-769662 and AMP Synergistically Activate Naive AMPK Independent of Upstream Kinase Signaling
- (2014) John W. Scott et al. CHEMISTRY & BIOLOGY
- A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
- (2014) G. Zadra et al. EMBO Molecular Medicine
- Association Between Metformin Use and Mortality in Patients With Prostate Cancer: Explained by Confounding by Indication?
- (2014) Marjolein M.J. Zanders et al. JOURNAL OF CLINICAL ONCOLOGY
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
- (2014) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
- (2014) H G Nguyen et al. ONCOGENE
- Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH
- (2014) Erin E. Mendoza et al. Translational Oncology
- Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growth
- (2014) E Tsouko et al. Oncogenesis
- Phytochemicals from Cruciferous Vegetables, Epigenetics, and Prostate Cancer Prevention
- (2013) Gregory W. Watson et al. AAPS Journal
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- AMPK Activation by Oncogenesis Is Required to Maintain Cancer Cell Proliferation in Astrocytic Tumors
- (2013) M. Rios et al. CANCER RESEARCH
- Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy
- (2013) Joungmok Kim et al. CELL
- The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
- (2013) Gabriel Leprivier et al. CELL
- AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
- (2013) D. G. Hardie DIABETES
- Metformin and the Incidence of Cancer in Patients With Diabetes: A Nested Case-Control Study
- (2013) Shu-Yi Wang et al. DIABETES CARE
- Agonists of luteinizing hormone-releasing hormone in prostate cancer
- (2013) Ferenc G Rick et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Time Is Ripe for a Randomized Trial of Metformin in Clinically Localized Prostate Cancer
- (2013) Kathryn L. Penney et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Metformin Use and Risk of Prostate Cancer and Its Grade
- (2013) David Margel et al. JNCI-Journal of the National Cancer Institute
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- Zinc transporters in prostate cancer
- (2013) M.-C. Franz et al. MOLECULAR ASPECTS OF MEDICINE
- Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
- (2013) Che-Hung Shen et al. MOLECULAR CELL
- AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1
- (2013) Ning Wu et al. MOLECULAR CELL
- Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch
- (2013) J B Tennakoon et al. ONCOGENE
- Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
- (2013) E H Allott et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Inhibition of Calcium/Calmodulin-Dependent Protein Kinase Kinase β and Calcium/Calmodulin-Dependent Protein Kinase IV Is Detrimental in Cerebral Ischemia
- (2013) Louise D. McCullough et al. STROKE
- An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
- (2013) Ferenc Rick et al. OncoTargets and Therapy
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- The influence of antidiabetic medications on the development and progression of prostate cancer
- (2012) Anna Hitron et al. Cancer Epidemiology
- Suppression of Tak1 Promotes Prostate Tumorigenesis
- (2012) M. Wu et al. CANCER RESEARCH
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level
- (2012) Thea Veitonmäki et al. EUROPEAN JOURNAL OF CANCER
- Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
- (2012) Daniel E. Spratt et al. EUROPEAN UROLOGY
- A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression
- (2012) Loukia G. Karacosta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK Regulates Mitotic Spindle Orientation through Phosphorylation of Myosin Regulatory Light Chain
- (2012) J. T. Thaiparambil et al. MOLECULAR AND CELLULAR BIOLOGY
- Androgens Promote Prostate Cancer Cell Growth through Induction of Autophagy
- (2012) Yan Shi et al. MOLECULAR ENDOCRINOLOGY
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Activation of AMP-Activated Protein Kinase by 3,3′-Diindolylmethane (DIM) Is Associated with Human Prostate Cancer Cell Death In Vitro and In Vivo
- (2012) Di Chen et al. PLoS One
- Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways
- (2012) Joseph C. Klink et al. PROSTATE
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
- (2012) S. A. Hawley et al. SCIENCE
- The changing landscape in the treatment of metastatic castration-resistant prostate cancer
- (2012) Joelle El-Amm et al. Therapeutic Advances in Medical Oncology
- Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
- (2011) L. Azoulay et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- PGC1 Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis
- (2011) K. Bhalla et al. CANCER RESEARCH
- The active form of the metabolic sensor AMP-activated protein kinase α (AMPKα) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia
- (2011) Rishi Raj Chhipa et al. CELLULAR SIGNALLING
- C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases
- (2011) Evan Y. Yu et al. CLINICAL NUCLEAR MEDICINE
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress
- (2011) K. Zaugg et al. GENES & DEVELOPMENT
- Regulation of LKB1 expression by sex hormones in adipocytes
- (2011) K J McInnes et al. INTERNATIONAL JOURNAL OF OBESITY
- Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks
- (2011) S. Alers et al. MOLECULAR AND CELLULAR BIOLOGY
- Chemical Genetic Screen for AMPKα2 Substrates Uncovers a Network of Proteins Involved in Mitosis
- (2011) Max R. Banko et al. MOLECULAR CELL
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- Androgen stimulates glycolysis forde novolipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells
- (2010) Jong-Seok Moon et al. BIOCHEMICAL JOURNAL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells
- (2010) Daniel E. Frigo et al. CANCER RESEARCH
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
- (2010) Simon A. Hawley et al. Cell Metabolism
- Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress
- (2010) Rishi Raj Chhipa et al. CELLULAR SIGNALLING
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation
- (2010) Atsushi Nakano et al. NATURE CELL BIOLOGY
- -Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK)
- (2010) J. S. Oakhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New prospective for non-invasive detection, grading, size evaluation, and tumor location of prostate cancer
- (2010) M. Cortesi et al. PROSTATE
- Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation
- (2010) D. Bungard et al. SCIENCE
- Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells
- (2010) H L Bennett et al. Cell Death & Disease
- 3,3′-Diindolylmethane induces a G1 arrest in human prostate cancer cells irrespective of androgen receptor and p53 status
- (2009) Omar I. Vivar et al. BIOCHEMICAL PHARMACOLOGY
- Proline Oxidase Functions as a Mitochondrial Tumor Suppressor in Human Cancers
- (2009) Y. Liu et al. CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells
- (2009) Griselda Herrero-Martín et al. EMBO JOURNAL
- Down-regulation of AMP-activated protein kinase sensitizes DU145 carcinoma to Fas-induced apoptosis via c-FLIP degradation
- (2009) Seung-Nam Jung et al. EXPERIMENTAL CELL RESEARCH
- Molecular mechanisms of castration-resistant prostate cancer progression
- (2009) Smitha S Dutt et al. Future Oncology
- AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity
- (2009) Satoshi Eguchi et al. GENES TO CELLS
- Regulation and function of proline oxidase under nutrient stress
- (2009) Jui Pandhare et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- 2-18F-Fluoropropionic Acid as a PET Imaging Agent for Prostate Cancer
- (2009) N. Pillarsetty et al. JOURNAL OF NUCLEAR MEDICINE
- AMP-activated protein kinase promotes human prostate cancer cell growth and survival
- (2009) H. U. Park et al. MOLECULAR CANCER THERAPEUTICS
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic
- (2008) Kei Sakamoto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
- (2008) Xu Huang et al. BIOCHEMICAL JOURNAL
- Lkb1 Deficiency Causes Prostate Neoplasia in the Mouse
- (2008) H. B. Pearson et al. CANCER RESEARCH
- Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo
- (2008) T. T.Y. Wang et al. CARCINOGENESIS
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
- (2008) Lisa Berglund et al. MOLECULAR & CELLULAR PROTEOMICS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
- (2008) Y Liu et al. ONCOGENE
- FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells
- (2008) A N Cornforth et al. ONCOGENE
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- AMP-activated protein kinase phosphorylates transcription factors of the CREB family
- (2007) D. M. Thomson et al. JOURNAL OF APPLIED PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started